TY - JOUR AU - Stone, J. H. AU - Zen, Y. AU - Deshpande, V. PY - 2012 DA - 2012// TI - IgG4-related disease JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMra1104650 DO - 10.1056/NEJMra1104650 ID - Stone2012 ER - TY - JOUR AU - Kamisawa, T. AU - Zen, Y. AU - Pillai, S. AU - Stone, J. H. PY - 2015 DA - 2015// TI - IgG4-related disease JO - Lancet. VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)60720-0 DO - 10.1016/S0140-6736(14)60720-0 ID - Kamisawa2015 ER - TY - JOUR AU - Moriyama, M. AU - Nakamura, S. PY - 2017 DA - 2017// TI - Th1/Th2 immune balance and other T helper subsets in IgG4-related disease JO - Curr Top Microbiol Immunol VL - 401 UR - https://doi.org/10.1007/82_2016_40 DO - 10.1007/82_2016_40 ID - Moriyama2017 ER - TY - JOUR AU - Gowthaman, U. AU - Chen, J. S. AU - Zhang, B. AU - Flynn, W. F. AU - Lu, Y. AU - Song, W. PY - 2019 DA - 2019// TI - Identification of a T follicular helper cell subset that drives anaphylactic IgE JO - Science VL - 365 UR - https://doi.org/10.1126/science.aaw6433 DO - 10.1126/science.aaw6433 ID - Gowthaman2019 ER - TY - JOUR AU - Della Torre, E. AU - Mattoo, H. AU - Mahajan, V. S. AU - Carruthers, M. AU - Pillai, S. AU - Stone, J. H. PY - 2014 DA - 2014// TI - Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease JO - Allergy. VL - 69 UR - https://doi.org/10.1111/all.12320 DO - 10.1111/all.12320 ID - Della Torre2014 ER - TY - STD TI - Culver EL, Sadler R, Bateman AC, Makuch M, Cargill T, Ferry B, et al. Increases in IgE, eosinophils, and mast cells can be used in diagnosis and to predict relapse of IgG4-related disease. Clin Gastroenterol Hepatol. 2017; 15(9): 1444–1452.e6. doi: https://doi.org/10.1016/j.cgh.2017.02.007. ID - ref6 ER - TY - JOUR AU - Wallace, Z. S. AU - Mattoo, H. AU - Mahajan, V. S. AU - Kulikova, M. AU - Lu, L. AU - Deshpande, V. PY - 2016 DA - 2016// TI - Predictors of disease relapse in IgG4-related disease following rituximab JO - Rheumatology (Oxford) VL - 55 UR - https://doi.org/10.1093/rheumatology/kev438 DO - 10.1093/rheumatology/kev438 ID - Wallace2016 ER - TY - JOUR AU - Wallace, Z. S. AU - Naden, R. P. AU - Chari, S. AU - Choi, H. K. AU - Della-Torre, E. AU - Dicaire, J. F. PY - 2020 DA - 2020// TI - The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease JO - Ann Rheum Dis VL - 79 UR - https://doi.org/10.1136/annrheumdis-2019-216561 DO - 10.1136/annrheumdis-2019-216561 ID - Wallace2020 ER - TY - JOUR AU - Wallace, Z. S. AU - Naden, R. P. AU - Chari, S. AU - Choi, H. K. AU - Della-Torre, E. AU - Dicaire, J. F. PY - 2020 DA - 2020// TI - The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease JO - Arthritis Rheumatol. VL - 72 UR - https://doi.org/10.1002/art.41120 DO - 10.1002/art.41120 ID - Wallace2020 ER - TY - JOUR AU - Wallace, Z. S. AU - Khosroshahi, A. AU - Carruthers, M. D. AU - Perugino, C. A. AU - Choi, H. AU - Campochiaro, C. PY - 2018 DA - 2018// TI - An international multispecialty validation study of the IgG4-related disease responder index JO - Arthritis Care Res (Hoboken) VL - 70 UR - https://doi.org/10.1002/acr.23543 DO - 10.1002/acr.23543 ID - Wallace2018 ER - TY - JOUR AU - Shirakashi, M. AU - Yoshifuji, H. AU - Kodama, Y. AU - Chiba, T. AU - Yamamoto, M. AU - Takahashi, H. PY - 2018 DA - 2018// TI - Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-018-28405-x DO - 10.1038/s41598-018-28405-x ID - Shirakashi2018 ER - TY - JOUR AU - Wang, L. AU - Zhang, P. AU - Wang, M. AU - Feng, R. AU - Lai, Y. AU - Peng, L. PY - 2018 DA - 2018// TI - Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients JO - Arthritis Res Ther VL - 20 UR - https://doi.org/10.1186/s13075-018-1567-2 DO - 10.1186/s13075-018-1567-2 ID - Wang2018 ER - TY - JOUR AU - Wallace, Z. S. AU - Deshpande, V. AU - Mattoo, H. AU - Mahajan, V. S. AU - Kulikova, M. AU - Pillai, S. AU - Stone, J. H. PY - 2015 DA - 2015// TI - IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients JO - Arthritis Rheumatol VL - 67 UR - https://doi.org/10.1002/art.39205 DO - 10.1002/art.39205 ID - Wallace2015 ER - TY - JOUR AU - Lin, W. AU - Lu, S. AU - Chen, H. AU - Wu, Q. AU - Fei, Y. AU - Li, M. PY - 2015 DA - 2015// TI - Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients JO - Rheumatology (Oxford) VL - 54 UR - https://doi.org/10.1093/rheumatology/kev203 DO - 10.1093/rheumatology/kev203 ID - Lin2015 ER - TY - STD TI - Borges T, Silva S. IgG4-related disease: how to place it in the spectrum of immune-mediated and rheumatologic disorders? [published online ahead of print, 2020 Jan 4]. Mod Rheumatol. 2020:1–8. https://doi.org/10.1080/14397595.2019.1705537. ID - ref15 ER - TY - STD TI - Fong W, Liew I, Tan D, Lim KH, Low A, Leung YY. IgG4-related disease: features and treatment response in a multi-ethnic cohort in Singapore. Clin Exp Rheumatol. 2018; 36 Suppl 112(3): 89–93. ID - ref16 ER - TY - JOUR AU - Nishida, K. AU - Gion, Y. AU - Takeuchi, M. AU - Tanaka, T. AU - Kataoka, T. R. AU - Yoshino, T. AU - Sato, Y. PY - 2018 DA - 2018// TI - Mast cells exhibiting strong cytoplasmic staining for IgE and high affinity IgE receptor are increased in IgG4-related disease JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-018-23043-9 DO - 10.1038/s41598-018-23043-9 ID - Nishida2018 ER - TY - JOUR AU - Vercelli, D. AU - Monte, L. AU - Monticelli, S. AU - Bartolo, C. AU - Agresti, A. PY - 1998 DA - 1998// TI - To E or not to E? Can an IL-4-induced B cell choose between IgE and IgG4? JO - Int Arch Allergy Immunol VL - 116 UR - https://doi.org/10.1159/000023918 DO - 10.1159/000023918 ID - Vercelli1998 ER - TY - JOUR AU - Punnonen, J. AU - Aversa, G. AU - Cocks, B. G. AU - McKenzie, A. N. AU - Menon, S. AU - Zurawski, G. PY - 1993 DA - 1993// TI - Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells JO - Proc Natl Acad Sci U S A VL - 90 UR - https://doi.org/10.1073/pnas.90.8.3730 DO - 10.1073/pnas.90.8.3730 ID - Punnonen1993 ER - TY - JOUR AU - Akiyama, M. AU - Yasuoka, H. AU - Yoshimoto, K. AU - Takeuchi, T. PY - 2018 DA - 2018// TI - Interleukin-4 contributes to the shift of balance of IgG subclasses toward IgG4 in IgG4-related disease JO - Cytokine. VL - 110 UR - https://doi.org/10.1016/j.cyto.2018.05.009 DO - 10.1016/j.cyto.2018.05.009 ID - Akiyama2018 ER - TY - JOUR AU - Yoon, H. K. AU - Shim, Y. S. AU - Kim, P. H. AU - Park, S. R. PY - 2019 DA - 2019// TI - The TLR7 agonist imiquimod selectively inhibits IL-4-induced IgE production by suppressing IgG1/IgE class switching and germline ε transcription through the induction of BCL6 expression in B cells JO - Cell Immunol VL - 338 UR - https://doi.org/10.1016/j.cellimm.2019.02.006 DO - 10.1016/j.cellimm.2019.02.006 ID - Yoon2019 ER - TY - JOUR AU - Saeki, T. AU - Kobayashi, D. AU - Ito, T. AU - Tamura, M. AU - Yoshikawa, S. AU - Yamazaki, H. PY - 2018 DA - 2018// TI - Comparison of clinical and laboratory features of patients with and without allergic conditions in IgG4-related disease: a single-center experience in Japan JO - Mod Rheumatol VL - 28 UR - https://doi.org/10.1080/14397595.2017.1416891 DO - 10.1080/14397595.2017.1416891 ID - Saeki2018 ER - TY - JOUR AU - Della-Torre, E. AU - Mattoo, H. AU - Mahajan, V. S. AU - Deshpande, V. AU - Krause, D. AU - Song, P. PY - 2014 DA - 2014// TI - IgG4-related midline destructive lesion JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2014-205187 DO - 10.1136/annrheumdis-2014-205187 ID - Della-Torre2014 ER - TY - JOUR AU - Lanzillotta, M. AU - Campochiaro, C. AU - Mancuso, G. AU - Ramirez, G. A. AU - Capurso, G. AU - Falconi, M. PY - 2020 DA - 2020// TI - Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes JO - Rheumatology (Oxford) VL - 59 UR - https://doi.org/10.1093/rheumatology/keaa221 DO - 10.1093/rheumatology/keaa221 ID - Lanzillotta2020 ER - TY - JOUR AU - Wang, X. D. AU - Zheng, M. AU - Lou, H. F. AU - Wang, C. S. AU - Zhang, Y. AU - Bo, M. Y. PY - 2016 DA - 2016// TI - An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011 JO - Allergy. VL - 71 UR - https://doi.org/10.1111/all.12874 DO - 10.1111/all.12874 ID - Wang2016 ER - TY - JOUR AU - Fu, Q. L. AU - Du, Y. AU - Xu, G. AU - Zhang, H. AU - Cheng, L. AU - Wang, Y. J. PY - 2016 DA - 2016// TI - Prevalence and occupational and environmental risk factors of self-reported asthma: evidence from a cross-sectional survey in seven Chinese cities JO - Int J Environ Res Public Health VL - 13 UR - https://doi.org/10.3390/ijerph13111084 DO - 10.3390/ijerph13111084 ID - Fu2016 ER - TY - JOUR AU - Mattoo, H. AU - Della-Torre, E. AU - Mahajan, V. S. AU - Stone, J. H. AU - Pillai, S. PY - 2014 DA - 2014// TI - Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy JO - Allergy. VL - 69 UR - https://doi.org/10.1111/all.12342 DO - 10.1111/all.12342 ID - Mattoo2014 ER - TY - JOUR AU - Della-Torre, E. AU - Germanò, T. AU - Ramirez, G. A. AU - Dagna, L. AU - Yacoub, M. R. PY - 2020 DA - 2020// TI - IgG4-related disease and allergen-specific immunotherapy JO - Ann Allergy Asthma Immunol VL - 124 UR - https://doi.org/10.1016/j.anai.2020.03.024 DO - 10.1016/j.anai.2020.03.024 ID - Della-Torre2020 ER - TY - JOUR AU - Peng, Y. AU - Li, J. Q. AU - Zhang, P. P. AU - Zhang, X. AU - Peng, L. Y. AU - Chen, H. PY - 2019 DA - 2019// TI - Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: a long-term cohort study JO - J Intern Med VL - 286 UR - https://doi.org/10.1111/joim.12942 DO - 10.1111/joim.12942 ID - Peng2019 ER - TY - JOUR AU - Khosroshahi, A. AU - Carruthers, M. N. AU - Deshpande, V. AU - Unizony, S. AU - Bloch, D. B. AU - Stone, J. H. PY - 2012 DA - 2012// TI - Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients JO - Medicine (Baltimore) VL - 91 UR - https://doi.org/10.1097/MD.0b013e3182431ef6 DO - 10.1097/MD.0b013e3182431ef6 ID - Khosroshahi2012 ER - TY - JOUR AU - Liu, Y. AU - Zeng, Q. AU - Zhu, L. AU - Gao, J. AU - Wang, Z. AU - Wang, Z. PY - 2020 DA - 2020// TI - Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort JO - Rheumatology (Oxford) VL - 59 UR - https://doi.org/10.1093/rheumatology/kez669 DO - 10.1093/rheumatology/kez669 ID - Liu2020 ER - TY - JOUR AU - Wallace, Z. S. AU - Zhang, Y. AU - Perugino, C. A. AU - Naden, R. AU - Choi, H. K. AU - Stone, J. H. PY - 2019 DA - 2019// TI - Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts JO - Ann Rheum Dis VL - 78 UR - https://doi.org/10.1136/annrheumdis-2018-214603 DO - 10.1136/annrheumdis-2018-214603 ID - Wallace2019 ER -